Technical Analysis for HCM - Hutchison China Meditech Limited
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Gilligan's Island Sell Setup | Bearish Swing Setup | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Multiple of Ten Bearish | Other | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
20 DMA Support | Bullish | 2.07% |
Alert | Time |
---|---|
Possible NR7 | about 17 hours ago |
2x Volume Pace | about 21 hours ago |
1.5x Volume Pace | about 21 hours ago |
Rose Above Previous Day's High | about 22 hours ago |
Gapped Up (Full) | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures markets and distributes prescription drugs and consumer health products in China.
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Healthcare Consumer Pharmaceutical Pharmaceuticals Life Sciences Disease Consumer Products Drugs Diseases Oncology Novation Autoimmune Diseases Innovation Pharmaceutical Industry In China Health Products Pharmaceuticals Policy Consumer Health Products
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Healthcare Consumer Pharmaceutical Pharmaceuticals Life Sciences Disease Consumer Products Drugs Diseases Oncology Novation Autoimmune Diseases Innovation Pharmaceutical Industry In China Health Products Pharmaceuticals Policy Consumer Health Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 338.0 |
52 Week Low | 173.6 |
Average Volume | 63,027 |
200-Day Moving Average | 257.08 |
50-Day Moving Average | 258.08 |
20-Day Moving Average | 275.15 |
10-Day Moving Average | 281.10 |
Average True Range | 14.41 |
RSI (14) | 63.77 |
ADX | 18.35 |
+DI | 29.92 |
-DI | 17.82 |
Chandelier Exit (Long, 3 ATRs) | 259.78 |
Chandelier Exit (Short, 3 ATRs) | 297.67 |
Upper Bollinger Bands | 296.03 |
Lower Bollinger Band | 254.27 |
Percent B (%b) | 1.0 |
BandWidth | 15.17 |
MACD Line | 7.09 |
MACD Signal Line | 6.74 |
MACD Histogram | 0.3569 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 307.23 | ||||
Resistance 3 (R3) | 308.31 | 305.66 | 305.36 | ||
Resistance 2 (R2) | 305.66 | 302.80 | 305.11 | 304.73 | |
Resistance 1 (R1) | 300.83 | 301.03 | 299.50 | 299.74 | 304.11 |
Pivot Point | 298.17 | 298.17 | 297.51 | 297.63 | 298.17 |
Support 1 (S1) | 293.34 | 295.31 | 292.02 | 292.26 | 287.89 |
Support 2 (S2) | 290.69 | 293.55 | 290.14 | 287.27 | |
Support 3 (S3) | 285.86 | 290.69 | 286.64 | ||
Support 4 (S4) | 284.77 |